Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate to Prevent Ischemic Cholangiopathy in DCD Liver Transplant
NCT05514119Phase 2Terminated
- Sponsor
- Mayo Clinic
- Start
- Aug 2022
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fenofibrate in ischemic cholangiopathy (IC), sponsored by Mayo Clinic. Started Aug 2022; status: terminated.
02
Drugs
fenofibrate
03
Conditions
ischemic cholangiopathy (IC)
Beyond the preview
Go deeper on NCT05514119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05514119.